Literature DB >> 6215829

Left ventricular hypertrophy improves cardiac performance in spontaneously hypertensive rats.

S Lundin, P Friberg, M Hallbäck-Nordlander.   

Abstract

Cardiac function was studied in spontaneously breathing, adult spontaneously hypertensive rats (SHR) and Wistar-Kyoto normotensive rats (WKY). By rapid intravenous blood infusion, the relation between left ventricular end-diastolic pressure (LVEDP) and stroke infusion, the relation between left ventricular end-diastolic pressure (LVEDP) and stroke volume (SV) was determined while the cardiac nervous control was pharmacologically blocked. Since SV is greatly influenced by the level of afterload (mean arterial pressure, MAP), SV was also determined at increased MAP (constriction of abdominal aorta) and at decreased MAP (vasodilation by hydralazine). At low LVEDP levels, a rightward shift of the Frank-Starling relationship was observed in SHR. This rightward shift seems mainly to depend on the increased MAP present in SHR since it was less prominent if MAP was lowered to normotensive levels in SHR. Maximal SV during volume infusion was similar in SHR and WKY, despite a much higher MAP in SHR. When peak SV was instead compared at similar MAP levels for both (either at normotensive' or 'hypertensive' levels) it was always significantly greater in SHR, and was increased largely in proportion to their increased left ventricular weight. This indicates that the left ventricular hypertrophy present in SHR is, at least at this stage, a physiological adaptation of the heart to increase its performance, in order to maintain a normal SV and hence cardiac output, despite an increased arterial pressure.

Entities:  

Mesh:

Year:  1982        PMID: 6215829     DOI: 10.1111/j.1748-1716.1982.tb06991.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  4 in total

1.  Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass.

Authors:  T Natsume; M B Kardon; B L Pegram; E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

Review 2.  Vascular changes in hypertension. Therapeutic implications.

Authors:  B Folkow
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 3.  Health- and performance-related potential of resistance training.

Authors:  M H Stone; S J Fleck; N T Triplett; W J Kraemer
Journal:  Sports Med       Date:  1991-04       Impact factor: 11.136

4.  Impairment of cardiac function and energetics in experimental renal failure.

Authors:  A E Raine; A M Seymour; A F Roberts; G K Radda; J G Ledingham
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.